Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,186 | -$6,170 | -$8,374 | -$17,549 |
| Dep. & Amort. | $119 | $186 | $183 | $118 |
| Deferred Tax | $0 | $0 | -$308 | -$2,379 |
| Stock-Based Comp. | $730 | $537 | $1,246 | $2,261 |
| Change in WC | -$986 | $571 | $308 | $2,891 |
| Other Non-Cash | $0 | -$15 | $308 | $2,379 |
| Operating Cash Flow | -$7,322 | -$4,890 | -$6,636 | -$12,279 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$30 | $0 | $0 |
| Stock Issued | $17,031 | $622 | $4,830 | $11,630 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,881 | $0 | $0 | $0 |
| Financing Cash Flow | $17,031 | $592 | $4,830 | $11,630 |
| Forex Effect | $46 | -$26 | $77 | -$93 |
| Net Chg. in Cash | $9,755 | -$4,324 | -$1,730 | -$748 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,037 | $5,361 | $7,091 | $7,839 |
| End Cash | $10,792 | $1,037 | $5,361 | $7,091 |
| Free Cash Flow | -$7,322 | -$4,890 | -$6,636 | -$12,285 |